Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (373)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
35
2026
2329
4.960
Why?
Machine Learning
8
2025
587
2.240
Why?
Stroke Volume
17
2025
652
1.890
Why?
Adrenergic beta-Antagonists
10
2025
250
1.540
Why?
Methadone
5
2023
122
1.430
Why?
Pregnancy Complications, Cardiovascular
5
2022
83
1.420
Why?
Buprenorphine
3
2023
191
1.310
Why?
Cardiomyopathies
5
2022
338
1.310
Why?
United States Food and Drug Administration
5
2024
205
1.200
Why?
Decision Support Systems, Clinical
6
2024
265
1.160
Why?
Pharmacogenetics
5
2024
173
1.120
Why?
Cardiomyopathy, Dilated
9
2025
359
1.120
Why?
Adverse Drug Reaction Reporting Systems
4
2024
81
1.080
Why?
Arrhythmias, Cardiac
6
2023
361
1.040
Why?
Cytochrome P-450 CYP2C19
4
2024
26
0.960
Why?
Electronic Health Records
7
2024
1177
0.950
Why?
Propanolamines
3
2019
40
0.900
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
439
0.860
Why?
Hospitalization
10
2024
2435
0.840
Why?
Workflow
2
2026
185
0.830
Why?
Telemedicine
4
2024
949
0.740
Why?
Atrial Fibrillation
5
2026
552
0.730
Why?
Torsades de Pointes
4
2016
23
0.710
Why?
Seasons
1
2024
556
0.700
Why?
Pulmonary Edema
1
2021
106
0.690
Why?
Humans
88
2026
144981
0.690
Why?
Coffee
1
2021
15
0.670
Why?
Pharmacogenomic Testing
4
2022
62
0.650
Why?
Stroke
2
2021
1259
0.630
Why?
Platelet Aggregation Inhibitors
1
2024
497
0.620
Why?
Aged
33
2026
25957
0.610
Why?
Defibrillators, Implantable
2
2021
382
0.610
Why?
Artificial Intelligence
2
2026
367
0.600
Why?
Prosthesis Failure
1
2020
128
0.590
Why?
Prosthesis-Related Infections
1
2020
99
0.580
Why?
Long QT Syndrome
3
2016
69
0.580
Why?
Mobile Applications
1
2021
196
0.570
Why?
Spironolactone
1
2019
39
0.570
Why?
Device Removal
1
2020
143
0.570
Why?
Risk Assessment
10
2026
3677
0.570
Why?
United States
22
2025
16000
0.570
Why?
Pacemaker, Artificial
1
2020
126
0.560
Why?
Medical Records
2
2019
190
0.560
Why?
Coronary Disease
1
2021
386
0.550
Why?
Mineralocorticoid Receptor Antagonists
1
2019
68
0.550
Why?
Diabetes Mellitus
2
2024
1098
0.540
Why?
Biomedical Research
2
2024
710
0.540
Why?
Periodicals as Topic
1
2020
203
0.540
Why?
Mortality
3
2019
376
0.520
Why?
Retrospective Studies
22
2026
17101
0.520
Why?
Hypertension, Pregnancy-Induced
1
2018
68
0.510
Why?
Female
50
2026
78387
0.500
Why?
Receptors, Transforming Growth Factor beta
1
2017
57
0.500
Why?
Hospital Records
1
2016
10
0.490
Why?
Proteoglycans
1
2017
110
0.480
Why?
Ventricular Function, Left
5
2025
541
0.480
Why?
Analgesics, Opioid
2
2023
1143
0.470
Why?
Hospital Mortality
6
2024
1035
0.470
Why?
Disease Management
1
2020
647
0.460
Why?
Survival
1
2015
38
0.460
Why?
Tetrazoles
1
2015
50
0.450
Why?
Male
42
2026
72416
0.450
Why?
Middle Aged
30
2025
35937
0.450
Why?
Electrocardiography
5
2026
663
0.440
Why?
Biphenyl Compounds
1
2015
68
0.440
Why?
Muscle Proteins
2
2025
244
0.430
Why?
Myocardial Infarction
3
2018
1210
0.420
Why?
Research Design
1
2020
1137
0.410
Why?
Ventricular Remodeling
3
2025
276
0.410
Why?
Loperamide
2
2023
12
0.400
Why?
Myocardium
3
2017
939
0.390
Why?
Diet
1
2021
1275
0.380
Why?
Polymorphism, Single Nucleotide
4
2017
2147
0.380
Why?
Tachycardia, Ventricular
1
2015
181
0.380
Why?
Registries
2
2020
2389
0.380
Why?
Precision Medicine
6
2024
458
0.370
Why?
Adult
28
2024
40511
0.370
Why?
Legislation, Medical
1
2012
11
0.370
Why?
Amiodarone
1
2012
31
0.370
Why?
Peripartum Period
4
2022
19
0.360
Why?
Phenotype
5
2025
3164
0.360
Why?
Patient Readmission
1
2018
759
0.360
Why?
Quality Improvement
2
2020
1292
0.350
Why?
Anti-Arrhythmia Agents
1
2012
143
0.340
Why?
Sex Factors
4
2024
2115
0.330
Why?
Pyrazines
2
2008
93
0.330
Why?
Catheter Ablation
1
2015
353
0.330
Why?
Heart Arrest
4
2019
407
0.330
Why?
Cardiovascular Diseases
5
2024
2175
0.320
Why?
Treatment Outcome
10
2025
11699
0.320
Why?
Transfusion Reaction
1
2011
63
0.320
Why?
Forecasting
2
2024
392
0.320
Why?
Triazoles
2
2008
184
0.320
Why?
Heart-Assist Devices
1
2016
567
0.320
Why?
Echocardiography
3
2024
653
0.310
Why?
Risk Factors
10
2025
10797
0.310
Why?
Postoperative Complications
2
2020
2920
0.300
Why?
Insurance, Health
1
2012
303
0.300
Why?
Patient Discharge
2
2021
984
0.300
Why?
Patient Transfer
1
2012
206
0.300
Why?
Anemia
1
2011
188
0.290
Why?
Thiazolidinediones
1
2010
139
0.290
Why?
Databases, Factual
5
2020
1486
0.290
Why?
Genotype
3
2024
1835
0.290
Why?
Marketing
1
2008
24
0.290
Why?
Renal Insufficiency
1
2011
169
0.280
Why?
Rhabdomyolysis
1
2008
24
0.280
Why?
Drug Industry
1
2008
49
0.280
Why?
Aged, 80 and over
7
2024
8282
0.280
Why?
Simvastatin
1
2008
60
0.280
Why?
Heart Ventricles
4
2017
760
0.280
Why?
Receptors, Adrenergic, beta-1
4
2019
24
0.280
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.270
Why?
Incidence
6
2025
2883
0.270
Why?
Heart Rate
3
2025
855
0.270
Why?
Follow-Up Studies
7
2025
5417
0.270
Why?
Length of Stay
4
2024
1337
0.260
Why?
Cytochrome P-450 CYP2D6
3
2022
32
0.260
Why?
Kaplan-Meier Estimate
3
2016
966
0.260
Why?
Proportional Hazards Models
4
2021
1325
0.260
Why?
Pharmacovigilance
2
2024
23
0.250
Why?
Practice Patterns, Physicians'
3
2020
1358
0.250
Why?
Elective Surgical Procedures
2
2020
201
0.240
Why?
Biological Specimen Banks
3
2024
103
0.240
Why?
Atrial Flutter
1
2026
45
0.230
Why?
Gene Expression Regulation
1
2015
2609
0.230
Why?
Emergency Service, Hospital
2
2020
2313
0.220
Why?
Patient Reported Outcome Measures
2
2020
489
0.220
Why?
Cause of Death
2
2019
472
0.220
Why?
New York
1
2024
127
0.210
Why?
Glucose
1
2010
1049
0.210
Why?
Diabetic Cardiomyopathies
1
2024
34
0.210
Why?
Pandemics
3
2022
1695
0.210
Why?
Young Adult
9
2022
14126
0.200
Why?
Pregnancy
6
2022
7191
0.200
Why?
Diphenoxylate
1
2023
5
0.200
Why?
Acute Kidney Injury
2
2008
868
0.200
Why?
Randomized Controlled Trials as Topic
3
2021
1722
0.190
Why?
Adolescent
10
2020
22453
0.190
Why?
Nonprescription Drugs
1
2023
65
0.190
Why?
Monitoring, Physiologic
1
2024
289
0.190
Why?
Heart Defects, Congenital
2
2020
914
0.180
Why?
Prognosis
5
2020
4294
0.180
Why?
Medicare
2
2020
889
0.180
Why?
Algorithms
4
2025
1839
0.180
Why?
Naltrexone
1
2023
118
0.180
Why?
Insulin Resistance
1
2010
1243
0.170
Why?
Speech
1
2021
77
0.170
Why?
Red Meat
1
2021
17
0.170
Why?
Hypertension
2
2020
1264
0.170
Why?
Time Factors
3
2020
7184
0.170
Why?
Losartan
1
2020
13
0.170
Why?
Lisinopril
1
2020
15
0.160
Why?
Data Interpretation, Statistical
2
2020
372
0.160
Why?
Drug Dosage Calculations
1
2020
27
0.160
Why?
Protective Factors
1
2021
99
0.160
Why?
Smartphone
1
2021
102
0.160
Why?
Angioedema
1
2020
15
0.160
Why?
Actigraphy
1
2021
145
0.160
Why?
Cardiac Resynchronization Therapy
1
2021
63
0.160
Why?
Wearable Electronic Devices
1
2021
63
0.160
Why?
American Heart Association
2
2019
352
0.160
Why?
Milk
1
2021
119
0.160
Why?
Hypoglycemic Agents
1
2010
1390
0.160
Why?
Turner Syndrome
1
2021
64
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
Indans
1
2020
13
0.160
Why?
Oxadiazoles
1
2020
37
0.150
Why?
Bionics
1
2019
14
0.150
Why?
Biological Products
1
2023
252
0.150
Why?
Editorial Policies
1
2020
46
0.150
Why?
California
2
2012
475
0.150
Why?
Medical Informatics
1
2020
97
0.150
Why?
Referral and Consultation
2
2017
853
0.150
Why?
Fingolimod Hydrochloride
1
2020
39
0.150
Why?
Medical Futility
1
2019
31
0.150
Why?
Medical Record Linkage
1
2020
68
0.150
Why?
Software
2
2015
692
0.150
Why?
Prescription Drugs
1
2020
111
0.150
Why?
Information Storage and Retrieval
1
2020
121
0.150
Why?
Drug Overdose
1
2023
370
0.140
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
82
0.140
Why?
Sitagliptin Phosphate
2
2008
31
0.140
Why?
Medical Order Entry Systems
1
2019
40
0.140
Why?
Drug Prescriptions
1
2021
285
0.140
Why?
Dose-Response Relationship, Drug
4
2020
2032
0.140
Why?
Child Health Services
1
2020
185
0.140
Why?
Tobacco Use
1
2019
61
0.140
Why?
Cohort Studies
3
2021
5966
0.140
Why?
Computer Graphics
2
2015
41
0.140
Why?
Cluster Analysis
1
2019
521
0.140
Why?
Social Determinants of Health
1
2022
303
0.140
Why?
Receptors, Histamine H2
1
2017
6
0.130
Why?
Gene Regulatory Networks
2
2023
320
0.130
Why?
Florida
1
2018
117
0.130
Why?
Advisory Committees
1
2019
230
0.130
Why?
Neisseria gonorrhoeae
1
1997
29
0.130
Why?
Porins
1
1997
18
0.130
Why?
Dyslipidemias
1
2019
182
0.130
Why?
Consensus
1
2019
490
0.130
Why?
Prospective Studies
4
2021
8000
0.130
Why?
Nursing Assessment
1
2017
56
0.130
Why?
Academic Medical Centers
1
2020
548
0.120
Why?
Pressure Ulcer
1
2017
43
0.120
Why?
Patient Participation
1
2020
433
0.120
Why?
Antihypertensive Agents
1
2020
511
0.120
Why?
Heart Diseases
1
2020
350
0.120
Why?
Population Surveillance
1
2020
485
0.120
Why?
Hospitals, Teaching
1
2017
119
0.120
Why?
Tilidine
1
2016
2
0.120
Why?
Cardiology
1
2019
356
0.120
Why?
Genetic Markers
1
2017
331
0.120
Why?
Double-Blind Method
3
2025
2029
0.120
Why?
Oxycodone
1
2016
53
0.110
Why?
Rheumatic Fever
1
2015
5
0.110
Why?
Rheumatic Heart Disease
1
2015
4
0.110
Why?
Databases, Genetic
1
2017
249
0.110
Why?
Sex Distribution
1
2016
386
0.110
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.110
Why?
Cholesterol Ester Transfer Proteins
1
2015
22
0.110
Why?
Angiotensin II
1
2015
97
0.110
Why?
Hospitals, Low-Volume
1
2015
26
0.110
Why?
Immunosuppressive Agents
1
2020
847
0.110
Why?
Gene Expression Profiling
3
2017
1786
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
758
0.110
Why?
Computational Biology
2
2017
681
0.110
Why?
Naloxone
1
2016
132
0.110
Why?
Hospitals, High-Volume
1
2015
50
0.110
Why?
Marijuana Use
1
2018
213
0.110
Why?
Mothers
1
2020
775
0.110
Why?
United Kingdom
1
2015
338
0.100
Why?
Percutaneous Coronary Intervention
1
2020
546
0.100
Why?
Biomarkers
2
2024
4276
0.100
Why?
Age Factors
2
2019
3335
0.100
Why?
International Classification of Diseases
1
2015
147
0.100
Why?
Comorbidity
1
2019
1660
0.100
Why?
Chronic Disease
2
2020
1813
0.100
Why?
Gene Expression
2
2017
1490
0.100
Why?
Down-Regulation
1
2015
627
0.100
Why?
MicroRNAs
2
2017
701
0.100
Why?
Narcotic Antagonists
1
2015
206
0.100
Why?
Cholesterol
1
2015
408
0.100
Why?
Ventricular Dysfunction, Left
2
2020
393
0.100
Why?
Federal Government
1
2012
23
0.090
Why?
Coronary Artery Disease
1
2019
742
0.090
Why?
Drug Resistance
1
2012
153
0.090
Why?
Myocytes, Cardiac
1
2017
556
0.090
Why?
RNA, Messenger
2
2017
2832
0.090
Why?
Area Under Curve
1
2012
331
0.090
Why?
Genetic Predisposition to Disease
2
2017
2365
0.090
Why?
Colorado
4
2024
4564
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
923
0.080
Why?
Predictive Value of Tests
1
2017
2118
0.080
Why?
Patient Safety
1
2015
349
0.080
Why?
Gastrointestinal Hemorrhage
1
2012
136
0.080
Why?
Anti-Retroviral Agents
1
2013
250
0.080
Why?
Opiate Substitution Treatment
1
2013
187
0.080
Why?
Bayes Theorem
1
2012
433
0.080
Why?
Managed Care Programs
2
2022
140
0.080
Why?
Survival Rate
1
2015
2092
0.080
Why?
Pregnancy Outcome
1
2013
476
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
237
0.080
Why?
Genome-Wide Association Study
1
2017
1407
0.080
Why?
Delivery of Health Care
1
2017
947
0.080
Why?
Multivariate Analysis
1
2012
1540
0.070
Why?
Severity of Illness Index
1
2017
2925
0.070
Why?
Pharmacogenomic Variants
2
2019
33
0.070
Why?
Primary Health Care
1
2019
1735
0.070
Why?
Drug Approval
1
2008
91
0.070
Why?
Emergency Medical Services
1
2015
696
0.070
Why?
Vasodilator Agents
1
2010
331
0.070
Why?
Logistic Models
1
2012
2119
0.060
Why?
Kidney Function Tests
1
2007
157
0.060
Why?
Animals
3
2023
38111
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
257
0.060
Why?
Zimbabwe
2
2017
76
0.060
Why?
Drug Therapy, Combination
1
2008
1048
0.060
Why?
Reproducibility of Results
2
2026
3416
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
36
0.050
Why?
Models, Biological
1
2012
1822
0.050
Why?
Case-Control Studies
1
2012
3609
0.050
Why?
Opioid-Related Disorders
1
2013
601
0.050
Why?
Canada
1
2026
429
0.050
Why?
Psychological Tests
1
2005
132
0.050
Why?
Potassium Channels
1
2025
145
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
40
0.050
Why?
Mandible
1
2004
72
0.050
Why?
Depression
2
2022
1559
0.050
Why?
Cross-Sectional Studies
3
2022
5873
0.050
Why?
Receptors, Adrenergic
1
2023
20
0.050
Why?
Drug Administration Schedule
2
2020
783
0.050
Why?
Cardiovascular Agents
1
2025
164
0.050
Why?
Carcinoembryonic Antigen
1
2002
39
0.050
Why?
Antigens, Differentiation
1
2002
77
0.040
Why?
Child
5
2020
22657
0.040
Why?
Antigens, Bacterial
1
2002
127
0.040
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Cell Adhesion Molecules
1
2002
178
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
11
0.040
Why?
Health Services Misuse
1
2020
36
0.040
Why?
Antigens, Neoplasm
1
2002
272
0.040
Why?
Insurance Claim Reporting
1
2020
26
0.040
Why?
Antidepressive Agents
1
2022
248
0.040
Why?
Lymphocyte Count
1
2020
164
0.040
Why?
Morbidity
1
2020
324
0.040
Why?
Membrane Glycoproteins
1
2002
496
0.040
Why?
Metoprolol
1
2019
26
0.040
Why?
Antineoplastic Agents
1
2010
2197
0.040
Why?
Grounded Theory
1
2019
46
0.040
Why?
Bias
1
2020
202
0.040
Why?
Aftercare
1
2020
224
0.040
Why?
Antigens, CD
1
2002
555
0.040
Why?
Genomics
1
2024
836
0.030
Why?
Mice, Transgenic
1
2023
2185
0.030
Why?
Coronary Angiography
1
2020
324
0.030
Why?
HIV Infections
1
2013
3154
0.030
Why?
Amino Acid Sequence
2
2002
2157
0.030
Why?
Delivery of Health Care, Integrated
1
2020
299
0.030
Why?
Static Electricity
1
1997
113
0.030
Why?
Molecular Sequence Data
2
2002
2931
0.030
Why?
Exercise Test
1
2020
634
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
104
0.030
Why?
Inpatients
1
2021
546
0.030
Why?
Frail Elderly
1
2017
134
0.030
Why?
Focus Groups
1
2019
573
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
341
0.030
Why?
Socioeconomic Factors
1
2020
1327
0.030
Why?
World Health Organization
1
2016
105
0.030
Why?
Metabolic Networks and Pathways
1
2017
187
0.030
Why?
Puerperal Disorders
1
2016
37
0.030
Why?
Physician-Patient Relations
1
2020
588
0.030
Why?
Neoplasms
1
2010
2884
0.030
Why?
Decision Trees
1
2015
82
0.030
Why?
Drug Combinations
1
2016
392
0.030
Why?
Data Mining
1
2015
117
0.030
Why?
Blood Pressure
1
2020
1769
0.030
Why?
Cell Membrane
1
1997
706
0.020
Why?
Biopsy
1
2017
1077
0.020
Why?
Pediatrics
1
2020
1115
0.020
Why?
Models, Genetic
1
2015
536
0.020
Why?
Liver
1
2020
1888
0.020
Why?
Infant
2
2015
10039
0.020
Why?
Mass Screening
2
2013
1348
0.020
Why?
Anthracyclines
1
2010
47
0.020
Why?
Child, Preschool
2
2015
11799
0.020
Why?
Trastuzumab
1
2010
118
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
114
0.020
Why?
Signal Transduction
1
2023
5233
0.020
Why?
Clinical Trials as Topic
1
2015
1055
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
225
0.020
Why?
Program Evaluation
1
2013
949
0.020
Why?
Apoptosis
1
2017
2430
0.020
Why?
Injections, Intravenous
1
2007
200
0.020
Why?
Natriuretic Peptide, Brain
1
2007
111
0.020
Why?
Ultrasonography
1
2010
770
0.020
Why?
Infusions, Intravenous
1
2007
423
0.020
Why?
Mice
1
2023
18366
0.010
Why?
Creatinine
1
2007
507
0.010
Why?
Hospitals, University
1
2005
176
0.010
Why?
Dentists
1
2004
21
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
988
0.010
Why?
Femur Neck
1
2004
62
0.010
Why?
Bone Diseases, Metabolic
1
2004
56
0.010
Why?
Absorptiometry, Photon
1
2004
276
0.010
Why?
Antibodies, Monoclonal
1
2010
1524
0.010
Why?
Nurses
1
2005
178
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
24
0.010
Why?
Analysis of Variance
1
2004
1311
0.010
Why?
Bone Density
1
2004
482
0.010
Why?
HeLa Cells
1
2002
650
0.010
Why?
Binding Sites
1
2002
1331
0.010
Why?
Clinical Competence
1
2005
1244
0.010
Why?
Physicians
1
2005
941
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)